Este programa tiene la intención de proveer conocimiento especializado, experiencia, comprensión de la fisiopatología y del manejo del paciente con insuficiencia cardiaca en sus diferentes grados, en particular estadios avanzados y areas como la creciente distincion de las distintas miocardiopatias, cardioreno metabolismo en IC y hipertension pulmonar. Nuevas áreas como el creciente papel de los dispositivos y las nuevas propuestas terapéuticas en el manejo y control diario de esta población

Publicaciones Miembros Diplomado Universidad Catolica Argentina 1.J Giorgi MD , R Cristodulo MD , C Vaca MD ,D Ureña MD , I Rejas MD J Rojas MD ,F Espinoza MD , E Kaplinsky MD ,A Barbagelata MD. Clinical and Epidemiological Profile of Heart Failure Patients with Chagas Disease: Insights from the SEPE-HF Registry. Am J Cardiol. 2025 Aug 18:S0002-9149(25)00486-2. doi: 10.1016/j.amjcard.2025.08.024 2.Tripoli, A., M. A. Samaniego, N. N. Gamarra-Valverde, S. P. Selvam, E. Kaplinsky, A. Barbagelata, M. Scandroglio and J. Giorgi (2025). "Efficacy and safety of apixaban versus vitamin K antagonists in patients with heartmate 3 fully magnetically levitated left ventricular assist device: a comprehensive meta-analysis." J Thromb Thrombolysis. 2025 Jul 1. doi: 10.1007/s11239-025-03141- 3.Vinh Q T Ho , Nghi Bao Tran, Nhan Nguyen, Giang Son Arrighini, David Downes, Mrunalini Dandamudi, Victoria Zecchin Ferrara, Tri Huynh Quang Ho, Hemank Walia, Alejandro Barbagelata,Thorsten M Leucker, Juliana Giorgi A PCSK9 Targeting Therapies for Familial Hypercholesterolemia: A Meta-Analysis of Efficacy on Lipid Biomarkers and Safety in Adults and Children Across 23 RCTs. Open Heart 2025;12:e003490. doi:10.1136/openhrt-2025-003490 4.Multiorgan failure during COVID-19 pandemic in cardiovascular patients. Role of advanced cardiac and pulmonary support Alejandro Barbagelata, Juliana Giorgi, Michael M Koerner, David A Baran Revista Argentina de Cardioangiologí¬a Intervencionista 2020;(02): 0058-0064 | Doi: 10.30567/RACI/202002/0058-0064 5.Cohen, J. B., T. C. Hanff, P. William, N. Sweitzer, N. R. Rosado-Santander, C. Medina, J. E. Rodriguez-Mori, N. Renna, T. I. Chang, V. Corrales-Medina, J. F. Andrade-Villanueva, A. Barbagelata, R. Cristodulo-Cortez, O. A. Diaz-Cucho, J. Spaak, C. E. Alfonso, R. Valdivia-Vega,M. Villavicencio-Carranza, R. J. Ayala-Garcia, C. A. Castro-Callirgos, L. A. Gonzalez-Hernandez,E. F. Bernales-Salas, J. C. Coacalla-Guerra, C. D. Salinas-Herrera, L. Nicolosi, M. Basconcel, J.B. Byrd, T. Sharkoski, L. E. Bendezu-Huasasquiche, J. Chittams, D. L. Edmonston, C. R. Vasquez and J. A. Chirinos (2021). "Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial." Lancet Respir Med 9(3): 275-284. 6.Cohen, J. B., T. C. Hanff, V. Corrales-Medina, P. William, N. Renna, N. R. Rosado-Santander, J. E. Rodriguez-Mori, J. Spaak, J. Andrade-Villanueva, T. I. Chang, A. Barbagelata, C. E. Alfonso, E. Bernales-Salas, J. Coacalla, C. A. Castro-Callirgos, K. E. Tupayachi-Venero, C. Medina, R. Valdivia, M. Villavicencio, C. R. Vasquez, M. O. Harhay, J. Chittams, T. Sharkoski, J. B. Byrd, D.L. Edmonston, N. Sweitzer and J. A. Chirinos (2020). "Randomized elimination and prolongation of ACE inhibitors and ARBs in coronavirus 2019 (REPLACE COVID) Trial Protocol." J Clin Hypertens (Greenwich) 22(10): 1780-1788. 7.Sergio V. Perrone, Alejandro Barbagelata, Fabián Diez, Jorge Franchella, Arnaldo Angelino Héroes, vectores o víctimasLos profesionales de la Salud requieren todos los recursosindispensables para luchar contra la pandemia de CoViD-19 (PDF) Héroes, vectores o víctimas: Los profesionales de la Salud requieren todos los recursos indispensables para luchar contra la pandemia de CoViD-19. INSUFICIENCIA CARDIACAInsuf Card 2020;15(2):52-62 8.J Giorgi, A Barbagelata.et al. ACC 2025 Latin America (oral presentation) - Efficacy of Cardiac Myosin Activators Compared to Placebo in Patients with Heart Failure and Reduced Ejection Fraction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials    9.J Giorgi, A Barbagelata et al ESC 2025 (moderate poster)- Exploring the Clinical and Mechanistic Impacts of the Nitroxyl Donors on Heart Failure Management: A Meta-Analysis of Hemodynamics Effects and Safety 10.J Giorgi, A Barbagelata et al AHA 2025 (moderate poster) - Comparative Analysis of Amiodarone Therapy in LVAD Recipients without diabetes: Impact on Heart Failure Outcomes and Adverse Events 11.Anker, S. D., J. Butler, G. Filippatos, J. P. Ferreira, E. Bocchi, M. Bohm, H. P. Brunner-La Rocca, D. J. Choi, V. Chopra, E. Chuquiure-Valenzuela, N. Giannetti, J. E. Gomez-Mesa, S. Janssens, J. L. Januzzi, J. R. Gonzalez-Juanatey, B. Merkely, S. J. Nicholls, S. V. Perrone, I. L. Pina, P. Ponikowski, M. Senni, D. Sim, J. Spinar, I. Squire, S. Taddei, H. Tsutsui, S. Verma, D. Vinereanu,J. Zhang, P. Carson, C. S. P. Lam, N. Marx, C. Zeller, N. Sattar, W. Jamal, S. Schnaidt, J. M. Schnee, M. Brueckmann, S. J. Pocock, F. Zannad, M. Packer and E. M.-P. T. Investigators (2021). "Empagliflozin in Heart Failure with a Preserved Ejection Fraction." N Engl J Med 385(16): 1451-1461. 12.Cristodulo Cortéz, R., D. Ureña Cordero, M. Sánchez, P. Rioja, W. Vida, E. Zambrana, N. Rojas, O. Escobar, J. Ibáñez, C. Vaca, S. V. Perrone and A. Barbagelata (2021). "Primer registro de insuficiencia cardíaca en la caja nacional de salud. Registro PRICNASA." Rev Fed Arg Cardiol. 50(3): 6. 13.Cristodulo, R., T. J.D., F. L.M., V. J.M., N. D. Rojas, S. J.S., V. J.A., E. Hornez, L. Lijerón, J. Montero, A. Barbagelata and M. Cristodulo (2025). "Registro de insuficiencia cardíaca en Santa Cruz de la Sierra, Bolivia. Registro SEPE-HF." Rev Argent Cardiol 93: 6. 14.Cristodulo, R., G. Luoma-Overstreet, F. Leite, M. Vaca, M. Navia, G. Duran, F. Molina, B. Zonneveld, S. V. Perrone, A. Barbagelata and E. Kaplinsky (2023). "Dengue Myocarditis: A Case Report and Major Review." Glob Heart 18(1): 41. 15.Anker, S. D., J. Butler, M. S. Usman, G. Filippatos, J. P. Ferreira, E. Bocchi, M. Bohm, H. P. B. Rocca, D. J. Choi, V. Chopra, E. Chuquiure, N. Giannetti, J. E. Gomez-Mesa, S. Janssens, J. L. Januzzi, J. R. Gonzalez-Juanatey, B. Merkely, S. J. Nicholls, S. V. Perrone, I. L. Pina, P. Ponikowski, M. Senni, D. Sim, J. Spinar, I. Squire, S. Taddei, H. Tsutsui, S. Verma, D. Vinereanu, J. Zhang, T. Iwata, J. M. Schnee, M. Brueckmann, S. J. Pocock and F. Zannad (2022). "Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved." Nat Med 28(12): 2512-2520. 16.Barbagelata, A., C. F. Bethea, H. W. Severance, R. J. Mentz, D. Albert, G. W. Barsness, V. T. Le, J. L. Anderson, T. J. Bunch, F. Yanowitz, B. Chisum, B. S. Ronnow and J. B. Muhlestein (2018). "Smartphone ECG for evaluation of ST-segment elevation myocardial infarction (STEMI): Design of the ST LEUIS International Multicenter Study." J Electrocardiol 51(2): 260-264. 17.Chyou, J. Y., W. T. Tay, J. Tromp, W. Ouwerkerk, K. H. Yiu, J. G. F. Cleland, S. P. Collins, C. E. Angermann, G. Ertl, U. Dahlstrom, K. Dickstein, S. V. Perrone, M. Ghadanfar, A. Schweizer, A. Obergfell, G. Filippatos and C. S. P. Lam (2025). "Prognostic Implications and Global Perspectives of Atrial Fibrillation in Patients Hospitalized for Heart Failure." JACC Heart Fail 13(3): 453-464.   18.Farah, A. and A. Barbagelata (2017). "Unmet goals in the treatment of Acute Myocardial Infarction: Review." F1000Res 6. 19.Giorgi, J., A. Barbagelata, G. Luoma-Overstreet, E. Kaplinsky, S. D. C. Jorge, M. Scanavacca, P. R. Scordamaglio and R. J. Mentz (2024). "3D Printing for Left Ventricular Assist Device Exchange: nsights From Real-World Experience." JACC Case Rep 29(5): 102194. 20.Kaplinsky, E., S. Perrone and A. Barbagelata (2023). "Emerging concepts in heart failure management and treatment: focus on vericiguat. Drugs Context. 2023 Jan 4; 12:2022-5-5. doi: 10.7573/dic.2022-5-5 21.Ospina Gonzalez, O. E., D. C. Llanos Mejia, E. Kaplinsky, A. Barbagelata and S. Perrone (2023). "Emerging concepts in heart failure management and treatment: focus on current guideline- directed medical therapy for heart failure with reduced ejection fraction. Drugs Context. 2023 Jan 4; 12:2022-6-4. doi: 10.7573/dic.2022-6-4. 22.Ruben, M., M. S. Molinas, H. Paladini, W. Khalife, A. Barbagelata, S. Perrone and E. Kaplinsky (2023). "Emerging concepts in heart failure management and treatment: focus on point-of-care ultrasound in cardiogenic shock. Drugs Context. 2023 Jan 4; 12:2022-5-8. doi: 10.7573/dic.2022-5-8 23.Swedzky, F., A. Barbagelata, S. Perrone, E. Kaplinsky and A. Ducharme (2023). "Emerging concepts in heart failure management and treatment: circulatory support with extracorporeal membrane oxygenation (ECMO). Drugs Context. 2023 Jan 4; 12:2022-7-7. doi: 10.7573/dic.2022-7-7. 24.Baez Cabanillas, M. V., R. Colque, M. A. Tibaldi, E. Kaplinsky, S. Perrone and A. Barbagelata (2023). "Emerging concepts in heart failure management and treatment: focus on tachycardia- induced cardiomyopathy. Drugs Context. 2023 Jan 4; 12:2022-8-4. doi: 10.7573/dic.2022-8-4. 25.Correlation of hemodynamic variables measured by impedance cardiography and right heart catheterization in pulmonary hypertension: a prospective cohort study F. Leonel Benaim, Franco S. Grazziani, Cecilia Villa Etchegoyen, Marcelo Boscaro, Edgardo Kaplinski, Alejandro Barbagelata Revista Argentina de Cardioangiología Intervencionista 26.Martinez, F., E. Perna, S. V. Perrone and A. S. Liprandi (2019). "Chagas Disease and Heart Failure: An Expanding Issue Worldwide." Eur Cardiol 14(2): 82-88. McNaughton, C. D., A. McConnachie, J. G. Cleland, J. A. Spertus, C. E. Angermann, P. Duklas, J. Tromp, C. S. P. Lam, G. Filippatos, U. Dahlstrom, K. Dickstein, A. Schweizer, S. V. Perrone, M. Hassanein, G. Ertl, A. Obergfell, M. Ghadanfar and S. P. Collins (2022). "Quality of life assessed 6 months after hospitalisation for acute heart failure: an analysis from REPORT-HF (international REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure)." Eur J Heart Fail 24(6): 1020-1029. 27.Muhlestein, J. B., J. L. Anderson, C. F. Bethea, H. W. Severance, R. J. Mentz, G. W. Barsness, A. Barbagelata, D. Albert, V. T. Le, T. J. Bunch, F. Yanowitz, H. T. May, B. Chisum, B. S. Ronnow, J. B. Muhlestein and i. Duke University Cooperative Cardiovascular Society (2020). "Feasibility of combining serial smartphone single-lead electrocardiograms for the diagnosis of ST-elevation myocardial infarction." Am Heart J 221: 125-135. 28.Muhlestein, J. B., J. B. Muhlestein, J. L. Anderson, C. F. Bethea, H. W. Severance, R. J. Mentz, G. W. Barsness, A. Barbagelata, D. Albert, V. T. Le, T. J. Bunch, F. Yanowitz, H. T. May, B. Chisum, B. S. Ronnow and i. Duke University Cooperative Cardiovascular Society (2020). "Smartphone 12-lead ECG-Exciting but must be handled with care." Am Heart J 226: 269. 29.Tay, W. T., T. K. Teng, W. Ouwerkerk, C. E. Angermann, K. Dickstein, J. G. F. Cleland, U. Dahlstrom,G. Ertl, M. Hassanein, S. V. Perrone, M. Ghadanfar, A. Schweizer, A. Obergfell, S. P. Collins, G. Filippatos, C. S. P. Lam and J. Tromp (2025). "Quality of care delivery in patients with acute heart failure: insights from the international REPORT-HF registry." EClinicalMedicine 80: 103031. 30.Facundo Pereyra, Francisco Schlottmann, Edgar Carnero Contenti, Carolina Salvatori, Sofía Barbagelata, Leandro Steinberg, Lisandro Pereyra. Gut–Brain Axis and Migraine: Rates of Improvement and Predictors of Response After a Low-FODMAP, Low-Starch and Low–Sucrose Dietary Intervention J Hum Nutr Diet. 2025 Aug;38(4): e70104. doi: 10.1111/jhn.70104